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Abstract: Liposomes and giant unilamellar vesicles (GUVs) in particular are excellent compartments
for constructing artificial cells. Traditionally, their use requires bench-top vesicle growth, followed
by experimentation under a microscope. Such steps are time-consuming and can lead to loss of
vesicles when they are transferred to an observation chamber. To overcome these issues, we present
an integrated microfluidic chip which combines GUV formation, trapping, and multiple separate
experiments in the same device. First, we optimized the buffer conditions to maximize both the yield
and the subsequent trapping of the vesicles in micro-posts. Captured GUVs were monodisperse
with specific size of 18 ± 4 µm in diameter. Next, we introduce a two-layer design with integrated
valves which allows fast solution exchange in less than 20 s and on separate sub-populations of
the trapped vesicles. We demonstrate that multiple experiments can be performed in a single chip
with both membrane transport and permeabilization assays. In conclusion, we have developed a
versatile all-in-one microfluidic chip with capabilities to produce and perform multiple experiments
on a single batch of vesicles using low sample volumes. We expect this device will be highly
advantageous for bottom-up synthetic biology where rapid encapsulation and visualization is
required for enzymatic reactions.
Keywords: lab-on-chip; inverted emulsion method; microfluidics; giant vesicles; giant unilamellar
vesicles (GUVs); bottom-up synthetic biology
1. Introduction
Reproducing complex cellular systems in a controlled manner is at the forefront of bottom-up
synthetic biology [1,2]. Techniques such as gentle hydration [3,4] and electroformation [5,6] are very
well established for producing lipid-based vesicles that are commonly used as artificial cells [7,8].
Lesser used techniques such as the inverted emulsion method [9,10] or microfluidics [11,12] are being
actively developed due to their abilities to encapsulate large biomolecules inside lipid vesicles while
still maintaining physiological buffers—both of which are important requirements in realizing the
dream of a functioning artificial cell [13–16]. Despite their clear advantages, these methods have
limitations which restricts the experimental possibilities.
A typical experiment involving giant unilamellar vesicles (GUVs) includes preparation and
transfer to a pre-coated observation chamber, followed by experimentation/visualization under a
microscope. This is a lengthy process which is not always suitable for time-sensitive experiments,
i.e., encapsulation of enzymatic reactions. In addition, during the harvesting and transfer process,
care must be taken to avoid bursting or leakage as this can result in the loss of a sub-population of
GUVs and lead to misrepresentative results. In the case of vesicles prepared via the inverted emulsion
method, contamination by the oil phase during the harvesting step presents an additional challenge.
While methods such as careful removal of the top oil layer with successive centrifugation steps [17] or
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the use of a syringe to pierce the bottom of the Eppendorf [18] can be used, they introduce additional
steps and can still lead to loss of vesicles.
Even after successful transfer to an observation chamber, continuous imaging for long time
periods while adding or removing external components is challenging. Batch-to-batch variations,
which are inherent to GUV preparation techniques, also require repeat experiments to avoid misleading
datasets. Many researchers have used microfluidics to overcome some of these issues by trapping and
observing vesicles inside various devices [2,19–21]. Our previous work and others have shown that it
is possible to trap GUVs in microfluidic channels with the aid of micrometer-sized features such as
posts or wells [21,22]. Recently, we introduced a high-throughput device which reduces within-batch
variations by trapping large numbers of GUVs from the same preparation [23]. Some researchers
have taken this one step further by performing vesicle production within microfluidic chips [24–27]
and even trapping them on the same platform for visualization and analysis [25,28,29]. Combining
production and experimentation in a single platform is highly advantageous as it reduces the overall
time from formation to observation and minimizes loss of sample. However, the double-emulsion
template method, which is considered the gold standard for on-chip production, is non-trivial and
requires complex setups [30–33].
In this communication, we present a straightforward microfluidic method to produce GUVs via an
on-chip inverted emulsion method. The resulting vesicles are then directly trapped using micro-posts
within the same device for observation and analysis. First, we optimize the buffer conditions to
maximize the yield of GUVs. Then, we characterize the size of vesicles before and after trapping,
as well the occupation efficiency. Furthermore, we show that the addition of more than one inlet
prevents the need to remove oil present in the reservoir where the inverted emulsion method is
performed. To increase the versatility of the device, sets of vesicles are isolated from each other with
the help of microfluidic valves, and multiple experiments are performed by solution exchange on
specific sub-populations. This approach not only addresses the aforementioned time factor but also
prevents batch-to-batch variations, as multiple conditions can be applied to the same preparation of
vesicles. After fluidic exchange is demonstrated using fluorescent dyes, different tests are carried out
on the same device, demonstrating its capability to perform multiple experiments. The use of on-chip
vesicle production via the inverted emulsion method opens up the possibility to encapsulate large
biomolecules such as enzymes, which is essential for the bottom-up creation of artificial cells.
2. Materials and Methods
2.1. Materials and Equipment
1-Palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC) was purchased from Avanti Polar Lipids
(Alabaster, AL, USA). 1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine-5,5′-disulfonic acid
(DiIC18), 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI), and calcein were purchased from
ThermoFisher Scientific (Waltham, MA, USA). Chloroform used for dissolving and storing lipid
stocks was purchased from Merck (Darmstadt, Germany) along with other reagents: glucose, sucrose,
Triton X-100, and light mineral oil (catalog code: 330779-1L). β-Casein and bovine serum albumin
(BSA) used to coat the glass coverslips were purchased from Sigma-Aldrich (Taufkirchen, Germany).
Materials for producing microfluidics chips, polydimethylsiloxane (PDMS) and curing agent, were
purchased as the SYLGARD® 184 silicone elastomer kit from Dow Corning (Midland, MI, USA).
1H,1H,2H,2H-Perfluorodecyltrichlorosilane was purchased from abcr GmbH (Karlsruhe, Germany).
Materials for the dye leakage assay, fluorescein and α-hemolysin (α-HL), were purchased from Sigma.
Millipore® MilliQ water was used to make all the aqueous solutions. Pressure was applied to the chip
using a nitrogen gas line via a custom-built device. Details of the operation can be found elsewhere [34].
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2.2. Solutions for the On-Chip Inverted Emulsion Method
A lipid–oil solution was made by drying 75 µL of 200 mM lipid mixture POPC:DiIC18 (99.5:0.5%)
in chloroform under argon flow. Residual chloroform was removed by desiccation for a period of
45 min. Mineral oil was added to the dried lipid film to make the total lipid concentration of 180 µM.
The vial containing the mixture was kept under bath sonication for a period of 30 min in degassing
mode to fully solubilize the lipids.
Sucrose and glucose sugar solutions, which were used to create a density gradient, were made by
dissolving respective amounts in MilliQ water to generate various concentrations: 100, 300, 600, and
900 mM.
2.3. Microfabrication
Fabrication of the microfluidic devices was performed using a procedure described previously [21].
Briefly, four-inch silicon wafers (Si-Mat, Kaufering, Germany) with the required design were produced
via soft photolithography to a height of 20 µm. Silicon wafers coated with SU8 3025 (Microchem,
Newton, MA, USA) were exposed to UV light through a film mask (Micro Lithography Services,
Chelmsford, UK) and un-exposed photoresist was removed. Salinization was performed by overnight
incubation with 50 µL of 1H,1H,2H,2H-perfluorodecyltrichlorosilane in a desiccator. PDMS-based
chips were produced by pouring the PDMS/curing agent mixture (10:1) on top of the silanized wafer,
and then curing at 90 ◦C for three hours. Cured PDMS was removed from the master mold, and holes
were punched at dedicated inlets and outlets using a 1.5-mm biopsy puncher (Kai Europe, Solingen,
Germany). This was followed by bonding to pre-cleaned glass coverslips using an air plasma treatment
(Plasma Cleaner PDC- 002-CE, Harrick Plasma, Ithaca, NY, USA) at 0.6 bar for 1 min. Two small
reservoirs made from 200 µL pipette tips, with capacities of 150 µL, were glued to the two inlets with
PDMS and cured for a period of 2 h at 80 ◦C. In the case of double-layer chips with valves, the top layer
with the circular valve design was produced similar to the procedure mentioned above. Instead of
bonding to the coverslip, the chips with top-layer design with 1-mm punched holes were bonded to the
bottom fluidic layer prepared by curing 40 µm height spin-coated PDMS on the corresponding master
mold. After successful alignment of the two layers, both were removed from the silicon wafer and
1.5 mm inlets and an outlet were punched. Final chips were prepared by bonding to glass coverslips
and the creation of fluidic reservoirs as above. Note that, unlike in previous works [21], this new
design comprises two inlets to separate vesicle formation from the new solutions, 108 traps, and a
modification of the trap dimensions to capture larger GUVs (see results section).
2.4. Microscopy
Images of the GUVs were taken using a confocal microscope (SP8, Leica microsystems, Weizlar,
Germany). Calcein was imaged with an excitation wavelength of 488 nm, and the emission was
collected between 498 nm and 540 nm. For DiIC18, the excitation wavelength was set to 551 nm and
emission was collected between 562 nm and 628 nm. DAPI was excited with 405 nm, and emission
was collected from 415 to 440 nm. For bright-field imaging of the microfluidic chip in color, an
epifluorescence microscope was used (AZ100, Nikon, Tokyo, Japan). Image analysis was conducted
using Fiji (ImageJ, National Institutes of Health, Bethesda, MD, USA).
3. Results and Discussion
3.1. Chip Design and Operation
The device design for on-chip production, trapping, and visualization of GUVs is shown in
Figure 1a. The device includes two inlets (one for GUV production, the other for solution exchange),
filters (Figure 1b) (to avoid unwanted blocking of the traps), 108 traps (in a 9 × 12 array), and a single
outlet. An enlargement of the two-post trap design is shown in Figure 1c. One of the inlets is used to
perform the inverted emulsion method and the other inlet is reserved for the addition of solutions
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during the subsequent experiments (Figure 1d). First, the chip is loaded with β-casein solution
(2 mg/mL) via centrifugation (10 min at 900× g) and incubated for 30 min to coat the channel surfaces
and avoid vesicle adhesion/rupture. This is followed by exchange with a glucose solution (80 µL)
(centrifugation for 3 min at 900× g) and layering of the lipid–oil mixture (60 µL) in one of the reservoirs.
After 30 min of incubation to form a lipid monolayer at the oil–water interface, a water-in-oil emulsion
is produced by mixing 7 µL of isosmotic aqueous sucrose solution with 200 µL of the lipid–oil mixture
in an Eppendorf tube. By mechanically agitating the suspension over an Eppendorf rack three times,
water-in-oil (W/O) emulsion droplets are produced. Compared to microfluidic production of W/O
droplets [35,36], the above method is time-effective and simple. While direct size tunability is not
possible without the use of microfluidic droplet formation, here we demonstrate that with specific
trap dimensions, partial size selection can be achieved (see below). Then, 50 µL of this emulsion
is added to the reservoir containing the interface monolayer (Figure 1d). At this stage, equivalent
volumes of glucose solution are added to the second reservoir to balance the hydrostatic pressure
across the chip. As a last step, the chip is centrifuged at 180× g for 3 min to pass the emulsion through
the monolayer and form GUVs. The resulting GUVs that are produced at the bottom of the inlet are
drawn into the traps by applying a flow using a syringe pump operating in withdraw mode (Base 120,
neMESYS pump, Cetoni, Korbussen, Germany). Once the single GUVs are trapped (Figure 1c; Video
S1, Supplementary Materials), the reservoir hosting the inverted emulsion is blocked, and solution
exchanges are performed through the other reservoir. The purpose of the second reservoir is to provide
fluid exchange without the need to remove any oil from the first reservoir. Without this, residual oil
can enter the traps, causing bursting and loss of GUVs (data not shown).
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3.2. On-Chip Giant Unilamellar Vesicle (GUV) Production and Trapping Occupancy
The existence of a density difference between the solutions inside and outside of the GUVs is
essential for their production using the inverted emulsion method [9,37]. Considering this, the on-chip
production of giant vesicles was investigated using various concentrations of sugar solutions: 100 mM,
300 mM, 600 mM, and 900 mM. After centrifugation, we first analyzed the size of the produced GUVs
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at the inlet. We found that for lower sugar concentrations, the vesicles are larger in size but with more
polydispersity (see Figure 2a). For the highest tested concentration of 900 mM, the average diameter
was reduced to 15 ± 3 µm, giving some control over the size of the vesicles.
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Figure 2. Optimization of the inverted emulsion method within the microfluidic device. (a) Distribution
of GUV sizes produced in the chip with various sugar concentrations. Mean diameters were 31 ± 8,
25 ± 4, 21 ± 4, and 15 ± 3 µm for 100, 300, 600, and 900 mM respectively. For comparison, the size of
the GUVs captured inside the microfluidic chip was 18 ± 4 µm in diameter. (b) Dependency of the
yield of vesicles and the occupancy of the traps with respect to the sugar concentration. The percentage
trapping occupancy was calculated by dividing the number of traps containing a GUV with that of total
number of traps (108) multiplied by 100. Mean values are given with error bars taken from standard
deviations (n = 3). Note that, for both cases, vesicles where counted manually.
Next, we investigated the yield at the inlet, as well as the occupancy of the traps with the different
sugar densities. Among the tested concentrations, both 600 mM and 900 mM conditions provided the
highest yield (Figure 2b). There is a clear dependency of the vesicle yield on the sugar concentration
(in agreement with previous studies [9]), which reaches a plateau at 600 mM. The GUVs were then
drawn into the chip (5 µL/min for at least 15 min or until the inlet was free from vesicles) in order
to examine the occupancy of the two-post traps (see Figure 1c for an example of a single trapped
GUV). The occupancy followed a similar trend to that of the GUV yield, with more traps being filled
with increasing sugar concentrations (Figure 2b). A aximum occupancy was reached at 60 ± 21%
for 600 mM sugar. This was most likely due to the limited number of available GUVs formed at the
inlet. A slight decrease at 900 mM, even though the yield was higher, was most likely due to a change
in vesicle size from 21 ± 4 to 15 ± 3 µm. Trapping posts have been shown to capture a specific size
range of GUVs [21], and here the mean diameter of the captured vesicles in the traps was 18 ± 4 µm
(Figure 2a). Considering that the average gap between the two posts is 11 ± 0.9 µm, smaller vesicles
(at 900 mM) are more likely to pass through trap and lower the overall probability of occupancy. In
general, the trapping occupancy could, in principle, be improved by increasing the volume of emulsion
and therefore the yield [9].
These data show that we are able to selectively tune the size of the GUVs under analysis. We note
that this can also be achieved with microfluidic formation methods [38], however here we provide
a much simpler set-up. Other sizes could be selected using different channel/trap dimensions [21].
For the proceeding experiments, a 600 mM sugar concentration was maintained for the production of
GUVs to maximize the number of GUVs under observation within the traps.
3.3. Two-Layer Design for Multiple Experiments
To introduce more versatility, another layer was added to the two-inlet design described above.
The second upper layer, situated above the previous fluidic layer, has circular valves over each of
the 108 traps. Upon the application of 2 bar of pressure to the upper layer, the PDMS is deformed in
a circular shape [21], making contact with the glass coverslip and therefore creating a sealed valve.
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Note that since PDMS is permeable to gas, direct usage of gas to pressurize the valves might result
in the development of air bubbles within channels. To circumvent this problem, the top layer was
filled with water via centrifugation at 900× g for 10 min. The purpose of the valves is to selectively
provide or prevent fluidic access to the trapped vesicles. This can be used as an advantage to perform
multiple independent experiments on a single batch of produced vesicles within the same chip. After
the production and trapping of the GUVs, it is possible to close all the valves, thus isolating all of the
GUVs from the external medium. By opening and closing specific valves, it is possible to selectively
expose a sub-population of GUVs to a new external solution whilst still isolating the other GUVs
from the new medium. The current design contains eight valves, thereby allowing eight independent
experiments each with up to 12–18 traps or GUVs. The two-layer chip design can be seen in Figure 3a
where the lower fluidic layer has the same design used for optimizing vesicle production (Figure 1).
Figure 3b shows a higher magnification of a single trap with a closed valve. Note that the magenta
food dye is excluded from the center of the trap, demonstrating the ability of the valves to isolate
the trap and, therefore, the GUV from the rest of the channel network. Dimensions of the valve and
chamber are provided in Figure 3c. A photograph of the final chip can be seen in Figure S1 in the
Supplementary Materials.
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Figure 3. The two-layer microfluidic chip for ultiple experi ents. (a) Color bright-field microscopy
image of the entire channel network. For visualization, the lo er fluidic layer with traps contained
magenta food dye, and the upper layer with valves contained green food dye. Scale bar corresponds to
1 mm. (b) Magnification of a single trap showing the alignment of the valve directly above the trapping
posts. Scale bar corresponds to 100 µm. (c) Dimensions of the valve and the width of the underlying
channel (dimensions are in micrometers).
A solution exchange experiment was perfor ed on the trapped GUVs to demonstrate the ability
of the two-layer design to deliver new solutions to a specific population of trapped GUVs (see Video S2,
Supplementary Materials). Calcein dye at a concentration of 20 µM in 600 mM glucose solution was
added to the second reservoir and flushed into the chips at a flow rate of 2 µL/min with the valves
opened. Once the entire device was filled with calcein, the valves were closed (2 bar) and the solution
in the chip was replaced with DAPI (20 µM in 600 mM glucose solution) using the same procedure. A
single set of valves were then opened (back to 0 bar) with no flow, and a time series was recorded of
the solution exchange process (Figure 4a). As can be seen from Figure 4b, complete fluidic exchange
occurred within 20 s as DAPI replaced calcein. Here, the solution exchange was purely diffusive as no
flow was present, but faster times can be achieved with flow (see Video S3, Supplementary Materials).
This assay was performed on a single set of valves demonstrating the ability of the device to produce,
trap, and perform solution exchange on a sub-population of GUVs only. Next, we present a series of
tests to demonstrate that multiple experiments can be conducted.
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3.3.1. Membrane Transport Assay
A calcein transport assay is presented using alpha-hemolysin membrane pore protein to
demonstrate the ability to perform multiple experiments on the same device. A solution of 2.5 µg/mL
alpha-hemolysin together with 20 µM calcein in 600 mM glucose was flushed through the device for a
period of 10 min at a flow rate of 2 µL/min while the valves of two rows were opened and the rest of the
valves were closed. From the data presented in Figure 5a, it is evident that the GUV was porous within
a few seconds as calcein can be seen within the lumen. Figure 5b shows the profile of calcein inside
the GUV over time (see Video S4, Supplementary Materials). Successful formation of a membrane
pore also confirms the unilamellarity of the membranes. This result shows that by using a two-inlet
design, one can perform entire GUV production, trapping, and analysis within the same chip without
requiring the removal of the residual oil left over in the production step. Importantly, this experiment
was performed independently from the solution exchange above, but on the same device.
Micromachines 2020, 11, x 7 of 11 
 
 
Figure 4. Solution exchange assay. (a) Confocal time-series of calcein and DAPI exchange after 
opening a set of valves. DiIC18 was used to stain the membrane of the GUVs, and bright-field images 
are included to visualize the valves. Scale bar 200 µm. (b) Mean fluorescence intensities of calcein and 
DAPI taken from the center of the valves (n = 3). Note that the valves were opened at 10 s. Shaded 
grey error bars are taken from the standard deviation. 
3.3.1. Membrane Transport Assay 
A calcein transport assay is presented using alpha-hemolysin membrane pore protein to 
demonstrate the ability to perform multiple experiments on the same device. A solution of 2.5 µg/mL 
alpha-hemolysin together with 20 µM calcein in 600 mM glucose was flushed through the device for 
a period of 10 mi  at a flow rate of 2 µL/min while the valves of two rows were opened and the rest 
of the valves were closed. From the data presented in Figure 5a, it is evident that the GUV was porous 
within a few seconds as calcein can be seen within the lumen. Figure 5b shows the profile of calcein 
inside the GUV over time (see Video S4, Supplementary Materials). Successful formation of a 
membrane pore also confirms the unila ellarity of the membranes. This result shows that by using 
a two-inlet design, one can perform e tire GUV production, trapping, and analysis within the same 
chip without requiring the removal of the residual oil left over in the production step. Importantly, 
this experiment was performed independently from the solution exchange above, but on the same 
device. 
 
Figure 5. Calcein dye transport assay using alpha-hemolysin membrane pore protein. (a) Confocal 
time-series of a trapped GUV (red) after exposure to the protein and calcein solution (green). Scale 
bar 50 µm. (b) Mean fluorescence intensity of calcein inside the GUVs over time (n = 3). Shaded grey 
error bars are taken from the standard deviation. 
Figure 5. Calcein dye transport assay using alpha-hemolysin membrane pore protein. (a) Confocal
time-series of a trappe GUV (red) after exposure to the protein a d calcein solution (gre n). Scale bar
50 µm. (b) M an fluo escence intensity of calcein in id he GUVs over time (n = 3). Shaded grey error
bars e taken from the standard deviation.
Micromachines 2020, 11, 285 8 of 11
3.3.2. Membrane Permeabilization and Rupture
GUVs that were isolated from the alpha-hemolysin assay were then used for a membrane
permeabilization and rupture test. After exchanging the external solution with 0.1% Triton X-100 and
20 µM calcein in 600 mM glucose, these isolated GUVs were exposed by opening the valves. Note that
even after more than an hour of valve pressure and the constant presence of multiple solutions, the
GUVs were perfectly stable and isolated. After opening of the valves, and in the presence of 2 µL/min
flow, the exchange of fluid happened within 10 s (see Video S3, Supplementary Materials). Figure 6
shows the permeabilization of the lipid bilayer by Triton X-100 via calcein dye penetration into the
lumen of a GUV at 21 s (see Video S5, Supplementary Materials) which is followed by rupture in the
next 2 s. It is well known that Triton X-100 can solubilize lipids [39], and these data show that before
complete solubilization and rupture, pores are formed which are large enough for small dye molecules
to cross the membrane. This last assay shows that not only can formation and trapping be conducted
on a single platform, but multiple separate experiments are also feasible.
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with ptimized sugar sol tion se at 600 mM and are then in roduced into an arr y of 108 traps
designed to cap ure single GUVs. The W/O emulsion is f rmed off-line in bulk so the resulting GUVs
formed at th device inl t ar polydisperse in iz . However, owing to the specific height (20 µm) and
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of forming GUVs and delivering new solutions on a microfluidic chip is that the required sample
volumes are greatly reduced compared to bulk methods. Being able to fully exchange external GUVs
solutions is not possible using bulk approaches. Here, we show that this is not only possible with our
platform, but it can also be performed in less than 10 s. We foresee the ability of this integrated device
to perform multiple experiments on a single batch of on-chip produced vesicles being applicable to
membrane biophysical studies, as well as the bottom-up construction of artificial cells.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-666X/11/3/285/s1,
Figure S1: Photographs of the fully assembled two layer device. Video S1: capture of a GUV into the two
post trap. Video S2: diffusive fluid exchange after opening the valve. Video S3: fast fluid exchange. Video S4:
alpha-hemolysin induced membrane transport. Video S5: membrane permeation and rupture assay.
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